Ava Graszl
Physician Assistant · Denver, CONPI 1699382846
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 28.3% of the total. Reporting peaked in 2023 at $717 and has fallen 90.4% since, to $69 in 2025.
Across 78 payments — averaging $22.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$505
- Galderma Laboratories, L.p.$314
- Lilly USA, LLC$161
- AstraZeneca$155
- Supernus Pharmaceuticals, Inc.$102
- Pfizer$78
- plus $470 from 14 others
What the payments were for
- Food & beverage$1,786100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $505 |
| Galderma Laboratories, L.p. | 5 | $314 |
| Lilly USA, LLC | 7 | $161 |
| AstraZeneca | 2 | $155 |
| Supernus Pharmaceuticals, Inc. | 5 | $102 |
| Pfizer | 4 | $78 |
| Sunovion Pharmaceuticals Inc. | 4 | $59 |
| Ironshore Pharmaceuticals Inc. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $55 |
| Gilead | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Johnson & Johnson | 2 | $41 |
| Adlon Therapeutics L.p. | 2 | $32 |
| Viiv Healthcare Company | 1 | $30 |
| GSK | 1 | $22 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Alkermes, Inc. | 1 | $18 |
| Exeltis, USA Inc. | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$126
How this compares
$1,786 in reported general payments places this provider in the 80th percentile of 2,849 physician assistant providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 33 | $216 |
| Levothyroxine Sodium | 16 | $183 |
| Lisinopril | 12 | $91 |
| Metformin Hcl | 13 | $83 |
| Losartan Potassium | 11 | $82 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Denver
- Kristen LervikDenver$131K
- Emily FrischDenver$79K
- Andrew GardnerDenver$68K
- Ethan MytingerDenver$19K
- Karen WilderDenver$16K
- Mariam MikeladzeDenver$12K
- Laura MurrayDenver$10K
- Corbin RogersDenver$10K
- Donald MooreEnglewood$246K
- Neekan AeiniGreenwood Village$234K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.